In a filing, Biohaven Ltd revealed its Director CHILDS JOHN W acquired Company’s shares for reported $1.0 million on Mar 04 ’25. In the deal valued at $30.47 per share,32,700 shares were bought. As a result of this transaction, CHILDS JOHN W now holds 2,320,571 shares worth roughly $34.37 million.
Then, CHILDS JOHN W bought 29,000 shares, generating $1,042,393 in total proceeds. Upon buying the shares at $35.94, the Director now owns 2,368,741 shares.
Before that, CHILDS JOHN W bought 21,052 shares. Biohaven Ltd shares valued at $999,970 were divested by the Director at a price of $47.50 per share. As a result of the transaction, CHILDS JOHN W now holds 21,052 shares, worth roughly $0.31 million.
RBC Capital Mkts downgraded its Biohaven Ltd [BHVN] rating to a Sector perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. Jefferies began covering BHVN with “Buy” recommendation on September 16, 2024. Bernstein started covering the stock on September 04, 2024. It rated BHVN as “an Outperform”.
Price Performance Review of BHVN
On Friday, Biohaven Ltd [NYSE:BHVN] saw its stock jump 0.47% to $14.81. Over the last five days, the stock has lost -4.02%. Biohaven Ltd shares have fallen nearly -60.35% since the year began. Nevertheless, the stocks have fallen -60.96% over the past one year. While a 52-week high of $55.70 was reached on 02/11/25, a 52-week low of $14.50 was recorded on 05/30/25. SMA at 50 days reached $20.50, while 200 days put it at $36.42.
Levels Of Support And Resistance For BHVN Stock
The 24-hour chart illustrates a support level at 14.37, which if violated will result in even more drops to 13.93. On the upside, there is a resistance level at 15.21. A further resistance level may holdings at 15.62. The Relative Strength Index (RSI) on the 14-day chart is 31.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.78%. Stochastics %K at 4.81% indicates the stock is a buying.
The most recent change occurred on July 24, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $58 price target.
